General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Medtronics(SIGNIFICANT), Philips(SIGNIFICANT), Terumo(MODEST), Abbott Laboratories(SIGNIFICANT), Boston Scientific(SIGNIFICANT) EQUITY INTERESTS/STOCK OPTIONS: AdvNanoT (ANT)(SIGNIFICANT) OFFICER, DIRECTOR ETC: NanoTherapies Inc(NONE) RESEARCH/RESEARCH GRANTS: Trireme(SIGNIFICANT) OTHER FINANCIAL BENEFIT: DISCOVERY THERAPEUTICS CARIBE, LLC (NONE)

View Full Disclosure